Status:
UNKNOWN
HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart Failure
Lead Sponsor:
Parkview Medical Center
Conditions:
Heart Failure, Diastolic
Brief Summary
In a retrospective community based cohort study from Pueblo County Colorado which has a higher population proportion of metabolic syndrome and diabetes mellitus, we hope to clarify and quantify an ass...
Detailed Description
The classic association of glycemic control, as represented by HBa1c, with progression or improvement of microvascular and macrovascular clinical complications has been well documented. Additionally, ...
Eligibility Criteria
Inclusion
- Stage A heart failure on basis of metabolic criteria
Exclusion
- LV dysfunction, valvular heart disease, hypertension and CAD
Key Trial Info
Start Date :
December 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04450576
Start Date
December 20 2019
End Date
December 30 2020
Last Update
November 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkview Medical Center
Pueblo, Colorado, United States, 81003